Search - tctmd.com

Displaying 101 - 120 of 139

Sort: Relevancy | Date

News Conference News ESC 2015

ABSORB Trials Pit BRS Against Second-Generation DES

Caitlin E. Cox

September 02, 2015

News Industry News

Micell Technologies Announces First Patient Enrolled in Registration Trial of MiStent SES in China

July 22, 2015

News Industry News

U.S. to vie with India for top bioabsorbable stent market after FDA approval

June 25, 2015

News Daily News

BRS Strut Width Tied to Increased Periprocedural MI

June 02, 2015

News Conference News EuroPCR 2015

Trials Explore the Potential of Biodegradable-Polymer Stents

Caitlin E. Cox

May 21, 2015

News Industry News

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

May 19, 2015

News Daily News

TE-PROVE: European Postapproval Study of PES Shows Safety in All-Comers

Yael L. Maxwell

January 28, 2015

News Daily News

TE-PROVE: Estudio Europeo Post-Aprobación de SLP Confirma la Seguridad en Pacientes No Seleccionados

Yael L. Maxwell

January 28, 2015

News Conference News AHA 2014

Biodegradable-Polymer DES Perform Well But Appear No Safer than Their Durable-Polymer Counterparts

November 18, 2014

News Daily News

OCT Study Suggests Plaque ‘Capping’ Safer With BRS Than BMS

November 06, 2014

News Conference News TCT 2014

COMPARE II: BES, EES Show Similar Outcomes at Three Years

September 13, 2014

News Conference News ESC 2014

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Yael L. Maxwell

September 01, 2014

News Daily News

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

Todd Neale

July 24, 2014

News Daily News

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

Yael L. Maxwell

July 03, 2014

News Daily News

Nationwide Registry Shows Trends in DES Use Over a Decade

June 02, 2014

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

News Conference News EuroPCR 2014

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

Caitlin E. Cox

May 20, 2014

News Daily News

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

L.A. McKeown

April 11, 2014

News Daily News

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

September 20, 2013

News Daily News

Contemporary ZES Perform Well in Treating In-Stent Restenosis

August 14, 2013

Advertisement

ABSORB Trials Pit BRS Against Second-Generation DES

Micell Technologies Announces First Patient Enrolled in Registration Trial of MiStent SES in China

U.S. to vie with India for top bioabsorbable stent market after FDA approval

BRS Strut Width Tied to Increased Periprocedural MI

Trials Explore the Potential of Biodegradable-Polymer Stents

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

TE-PROVE: European Postapproval Study of PES Shows Safety in All-Comers

TE-PROVE: Estudio Europeo Post-Aprobación de SLP Confirma la Seguridad en Pacientes No Seleccionados

Biodegradable-Polymer DES Perform Well But Appear No Safer than Their Durable-Polymer Counterparts

OCT Study Suggests Plaque ‘Capping’ Safer With BRS Than BMS

COMPARE II: BES, EES Show Similar Outcomes at Three Years

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

Nationwide Registry Shows Trends in DES Use Over a Decade

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

Contemporary ZES Perform Well in Treating In-Stent Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content